Histanaz
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
29978-129 -
Package NDC
29978-129-10 -
Application number
M012 -
SPL ID
5013a487-2901-ef02-e063-6394a90a2902 -
SPL set ID
3e87d0f3-f16c-5972-e063-6294a90acc8a -
UNII
6V9V2RYJ8N -
UNII
R35D29L3ZA -
RxCUI
2727351
What the source publishes
- Labeler
- Capital Pharmaceutical, LLC
- Active ingredients
- Pseudoephedrine HCL, Pyrilamine Maleate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- OTC MONOGRAPH DRUG
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "Histanaz",
"splId": "5013a487-2901-ef02-e063-6394a90a2902",
"labels": [
{
"setId": "3e87d0f3-f16c-5972-e063-6294a90acc8a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e87d0f3-f16c-5972-e063-6294a90acc8a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e87d0f3-f16c-5972-e063-6294a90acc8a"
}
],
"routes": [
"ORAL"
],
"labeler": "Capital Pharmaceutical, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (29978-129-10)",
"package_ndc": "29978-129-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20250908"
}
],
"productId": "29978-129_5013a487-2901-ef02-e063-6394a90a2902",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "29978-129",
"deaSchedule": null,
"genericName": "Pseudoephedrine HCL, Pyrilamine Maleate",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
"strength": "60 mg/1"
},
{
"name": "PYRILAMINE MALEATE",
"strength": "30 mg/1"
}
],
"applicationNumber": "M012",
"marketingCategory": "OTC MONOGRAPH DRUG",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250908",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"unii": [
"6V9V2RYJ8N",
"R35D29L3ZA"
],
"rxcui": [
"2727351"
],
"spl_set_id": [
"3e87d0f3-f16c-5972-e063-6294a90acc8a"
],
"manufacturer_name": [
"Capital Pharmaceutical, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:29978-129_5013a487-2901-ef02-e063-6394a90a2902"